Global Access Atlas

Filters

Choose one market

Market access pathways by country

Explore how an innovative medicine moves from approval to patient access.

Selected market

Mexico

COFEPRIS registration is followed by health-technology and formulary decisions across public institutions.

COFEPRIS

CSG / institutions

Public institutions

IMSS / ISSSTE / others

4 decision nodes11 cited sources

For education only — not regulatory, pricing or legal advice.

About the content and how to use it

Evidence checked through 2026-08-01A pathway is a decision map—not a launch-time promise

Locate the relevant route first

These choices define how to read the branches below. They do not predict a payer or provider decision.

1

Which institution purchases?IMSS, ISSSTE, IMSS-Bienestar and other public institutions control their own demand and implementation.

Selected routeIMSS9 applicable nodes

Authorization-to-patient timeline

See the selected route reach the patient

Updates immediately when a choice changes

1

CMN/SEPB opinionregistration dossier

2

Registrationsale/CNIS

3

CNIS applicationDOF key

4

Institutional adoptionprocurement forecast

5

Demand consolidationtender

6

Procurementdelivery

7

Receipt/distributiondispensing

8

Patient authorizationfirst patient

9

First funded patientEligible patient + capable provider + authorization + product + clean payment

1No obsolete commission shown

2CNIS key and institution list verified

3Demand appears in procurement

4Contract, delivery and stock proven

Do not collapse these decisions

Mexico's former patented-drug price negotiation commission was abolished in 2021. It must not appear as a current mandatory national step.

Decision map

What each local node actually produces

Select a row to inspect legal effect and downstream gates

#Local decision / ownerDecision outputDownstream dependencyEvidence

Decision question

evidence package supports filing/new molecule discussion?

Required evidence / materials

clinical/nonclinical/quality, indication

Can iterate or branch

questions/new meeting

Source date

MX-S02 · updated 2026-02-11

Node linked to cited dossier sourcesProduct/provider execution still requires live verification

Special mechanisms and lifecycle

What can reopen price, coverage or procurement after launch

Dates below come from the cited policy record—not a product forecast

Mechanism / triggerDecision outputIteration / branchPolicy recordLatest observed

Lifecycleupdate/rebid/removerecurringMX-S01 · MX-S04 · MX-S112026-07

CNIS updateInstitutional demand cycleTender/contract renewalSupply and shortage management

Evidence & policy library

Official basis and policy dates

11 records · checked 2026-08-01

MX-S01 · COFEPRIS · New Medicine Registration / Health Registrations VisorPolicy / effective: updated 2026-05; visor 2026-04 · Latest observed 2026-05registration/timing/status; actual clock product-specific MX-S02 · COFEPRIS · Comité de Moléculas NuevasPolicy / effective: updated 2026-02-11 · Latest observed 2026-02consultative opinion, not approval MX-S03 · COFEPRIS · Abbreviated Regulatory Pathway (Reliance)Policy / effective: 2026-06-16 · Latest observed 2026-06eligible reliance/equivalence; detailed guide required MX-S04 · CSG · CNIS 2025 and 2026 update agreementsPolicy / effective: 2025 edition, updates through 2026-07-03 · Latest observed 2026-07live national keys; not procurement MX-S05 · CSG/DOF · CNIS Commission Norms and FAQPolicy / effective: norms modified 2025-04-17 · Latest observed 2025-06 FAQapplication/evidence/institution boundary MX-S06 · IMSS · Institutional Lists — MedicinesPolicy / effective: current · Latest observed 2026representative IMSS prescribing list; not other institutions MX-S07 · Health Secretariat/Birmex/DOF · 2025–2026 Consolidated Procurement Model and GuidelinesPolicy / effective: 2024 guidelines for 2025–26 · Latest observed 2026roles/procurement; named tender/contract needed MX-S08 · Presidency/DOF · Agreement abolishing Price Negotiation CommissionPolicy / effective: 2021-07-20 · Latest observed current legal statusproves historical commission is not current MX-S09 · IMSS-Bienestar · Institutional mission/servicesPolicy / effective: current · Latest observed 2026non-social-security route; local coverage still needed MX-S10 · DOF/Health · NOM-072-SSA1-2012 labellingPolicy / effective: current labelling rule · Latest observed currentretail MRP label; not public net price MX-S11 · COFEPRIS/IMPI/DOF · 2025 Pharmaceutical Patent Linkage AgreementPolicy / effective: 2025-03-06 · Latest observed 2025generic/biocomparable patent observation